• Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression 

      Abdulrahman, Nabeel; Ibrahim, Meram; Joseph, Jensa Mariam; Elkoubatry, Hanan Mahmoud; Al-Shamasi, Al Anood; ... more authors ( Springer , 2022 , Article)
      Diabetes mellitus (DM)-induced cardiac morbidities have been the leading cause of death among diabetic patients. Recently, sodium-glucose cotransporter-2 (SGLT-2) inhibitors including empagliflozin (EMPA), which have been ...
    • Undergraduate student research 

      Ibrahim, Meram; Mukhalalati, Banan; Al alawneh, Majdoleen; Awaisu, Ahmed ( Qatar University Press , 2020 , Poster)
      Introduction: The United Nations launched the Sustainable Development Goals in 2015. One of these goals describes achieving a Universal Health Coverage by 2030. This signifies workforce planning in healthcare professions ...